1-7 of 7
Julio Delgado
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

Aina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta, Verónica González-Calle, Sergio Navarro-Velázquez, Susana Inogés, Ascensión López-Díaz de Cerio, Valentín Cabañas, Nieves López-Muñoz, Paula Rodríguez-Otero, Juan Luis Reguera, David F. Moreno, Nuria Martínez-Cibrian, Lucía López-Corral, Lorena Pérez-Amill, Beatriz Martin-Antonio, Laura Rosiñol, Joan Cid, Natalia Tovar, Joaquín Sáez-Peñataro, Miriam López-Parra, Eulalia Olesti, Elena Guillén, Sara Varea, Luis Gerardo Rodríguez-Lobato, Anthony M. Battram, Marta Sonia González, Andrés Sánchez-Salinas, Azucena González-Navarro, Valentín Ortiz-Maldonado, Julio Delgado, Felipe Prósper, Manel Juan, Joaquín Martínez-López, José M. Moraleda, Maria Victoria Mateos, Álvaro Urbano-Ispizua, Bruno Paiva, Mariona Pascal, Carlos Fernández de Larrea
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2085–2096.
https://doi.org/10.1158/1078-0432.CCR-23-3759
Published: 15 May 2024
View article titled, Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
Open the PDF for Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study

Alfredo Rivas-Delgado, Ferran Nadeu, Anna Enjuanes, Sebastián Casanueva-Eliceiry, Pablo Mozas, Laura Magnano, Natalia Castrejón de Anta, Jordina Rovira, Ivan Dlouhy, Silvia Martín, Miguel Osuna, Sonia Rodríguez, Marc Simó, Magda Pinyol, Tycho Baumann, Silvia Beà, Olga Balagué, Julio Delgado, Neus Villamor, Xavier Setoain, Elías Campo, Eva Giné, Armando López-Guillermo
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (2): 513–521.
https://doi.org/10.1158/1078-0432.CCR-20-2558
Published: 19 January 2021
View article titled, Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study
Open the PDF for Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study

Matthew S. Davids, Bryone J. Kuss, Peter Hillmen, Marco Montillo, Carol Moreno, James Essell, Nicole Lamanna, Zsolt Nagy, Constantine S. Tam, Stephan Stilgenbauer, Paolo Ghia, Julio Delgado, Stephanie Lustgarten, David T. Weaver, Hagop Youssoufian, Ulrich Jäger
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (9): 2096–2103.
https://doi.org/10.1158/1078-0432.CCR-19-3061
Published: 01 May 2020
View article titled, Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study
Open the PDF for Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study in another window
Includes: Supplementary data
Journal Articles

The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome

Christian Brieghel, Caspar da Cunha-Bang, Christina Westmose Yde, Ane Yde Schmidt, Savvas Kinalis, Ferran Nadeu, Michael Asger Andersen, Line Offenbach Jacobsen, Mette Klarskov Andersen, Lone Bredo Pedersen, Julio Delgado, Tycho Baumann, Mattias Mattsson, Larry Mansouri, Richard Rosenquist, Elias Campo, Finn Cilius Nielsen, Carsten Utoft Niemann
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1507–1515.
https://doi.org/10.1158/1078-0432.CCR-18-4158
Published: 13 March 2020
View article titled, The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome
Open the PDF for The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome in another window
Includes: Supplementary data
Journal Articles

Immobilizing A Moving Target: CAR T Cells Hit CD22

Sonia Guedan, Julio Delgado
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (17): 5188–5190.
https://doi.org/10.1158/1078-0432.CCR-19-1649
Published: 03 September 2019
View article titled, Immobilizing A Moving Target: CAR T Cells Hit CD22
Open the PDF for Immobilizing A Moving Target: CAR T Cells Hit CD22 in another window
Journal Articles

The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia

Alba Matas-Céspedes, Anna Vidal-Crespo, Vanina Rodriguez, Neus Villamor, Julio Delgado, Eva Giné, Heleia Roca-Ho, Pablo Menéndez, Elías Campo, Armando López-Guillermo, Dolors Colomer, Gaël Roué, Adrian Wiestner, Paul W.H.I. Parren, Parul Doshi, Jeroen Lammerts van Bueren, Patricia Pérez-Galán
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (6): 1493–1505.
https://doi.org/10.1158/1078-0432.CCR-15-2095
Published: 14 March 2017
View article titled, The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia
Open the PDF for The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia in another window
Includes: Supplementary data
Journal Articles

MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome

Jordina Rovira, Kennosuke Karube, Alexandra Valera, Dolors Colomer, Anna Enjuanes, Lluís Colomo, Alejandra Martínez-Trillos, Eva Giné, Ivan Dlouhy, Laura Magnano, Julio Delgado, Antonio Martínez, Neus Villamor, Elías Campo, Armando López-Guillermo
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (11): 2755–2764.
https://doi.org/10.1158/1078-0432.CCR-15-1525
Published: 31 May 2016
View article titled, <em>MYD88</em> L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome
Open the PDF for <em>MYD88</em> L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome in another window
Includes: Supplementary data